We are live on ! Find out more
CORZ icon

Core Scientific

189 hedge funds and large institutions have $1.14B invested in Core Scientific in 2024 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

530% more capital invested

Capital invested by funds: $181M → $1.14B (+$957M)

445% more first-time investments, than exits

New positions opened: 109 | Existing positions closed: 20

350% more funds holding in top 10

Funds holding in top 10: 29 (+7)

205% more call options, than puts

Call options by funds: $234M | Put options by funds: $77M

110% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 20

87% more funds holding

Funds holding: 101189 (+88)

40.5% more ownership

Funds ownership: 28.72%69.22% (+41%)

Holders
189
Holders Change
+88
Holders Change %
+87.13%
% of All Funds
2.73%
Holding in Top 10
9
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+350%
% of All Funds
0.13%
New
109
Increased
42
Reduced
20
Closed
20
Calls
$234M
Puts
$77M
Net Calls
+$157M
Net Calls Change
+$109M
Name Holding Trade Value Shares
Change
Change in
Stake
JCM
26
JAT Capital Management
Connecticut
$8.65M +$4.75M +930,000 New
Tudor Investment Corp
27
Tudor Investment Corp
Connecticut
$8.36M +$4.08M +798,787 +800%
N
28
Nuveen
North Carolina
$8.05M +$4.42M +866,086 New
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$7.89M +$4.33M +848,459 New
Morgan Stanley
30
Morgan Stanley
New York
$7.85M +$3.82M +748,064 +778%
ETC
31
Exchange Traded Concepts
Oklahoma
$7.26M -$3.83M -750,492 -49%
MA
32
MYDA Advisors
New York
$6.93M +$792K +155,000 +26%
Barclays
33
Barclays
United Kingdom
$6.85M +$2.74M +536,235 +268%
IECM
34
Intrinsic Edge Capital Management
Illinois
$6.77M +$3.21M +628,176 +628%
UBS Group
35
UBS Group
Switzerland
$6.74M +$3.7M +723,621 +63,420%
ACG
36
Aventail Capital Group
New York
$6.39M +$3.51M +686,832 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$6.27M +$3.34M +653,838 +3,236%
BHCM
38
Brevan Howard Capital Management
Jersey
$5.92M +$2.17M +424,179 +200%
RP
39
Regal Partners
Australia
$5.41M +$2.97M +581,188 New
Bank of America
40
Bank of America
North Carolina
$5.23M +$2.39M +467,649 +495%
William Blair & Company
41
William Blair & Company
Illinois
$4.83M +$984K +192,580 +59%
STA
42
Summit Trail Advisors
New York
$4.81M +$3.55M +694,079 New
KAM
43
Kirkoswald Asset Management
New York
$4.7M +$2.58M +505,000 New
PI
44
Pennant Investors
New Jersey
$4.65M +$2.55M +500,000 New
SM
45
Scoggin Management
New York
$4.65M +$2.55M +500,000 New
KPF
46
K2 Principal Fund
Ontario, Canada
$4.45M +$2.02M +394,629 +473%
HVCM
47
Hel Ved Capital Management
Hong Kong
$4.39M +$2.41M +471,557 New
SSA
48
Schonfeld Strategic Advisors
New York
$4.39M +$2.22M +434,506 +1,174%
Northern Trust
49
Northern Trust
Illinois
$4.33M +$2.25M +440,537 +1,794%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$4.22M +$2.32M +453,925 New

CORZ Hedge Fund Activity: Q2 2024 in Review

189 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Core Scientific (CORZ) for Q2 2024, worth a combined $1.14B — up 530% from $181M a quarter earlier.

Buyers outnumbered sellers: 109 funds opened new CORZ positions and 20 closed out — a net gain of 89 holders — while 42 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $62.2M. The largest seller was Barings, exiting entirely with an estimated $36.5M sold.

  • 189 institutional investors held Core Scientific (CORZ) as of Q2 2024, up from 101 in Q1 2024.
  • Funds reported $1.14B of Core Scientific stock for Q2 2024, up 530% quarter-over-quarter.
  • 109 funds opened new Core Scientific positions in Q2 2024 and 20 closed out, a net change of +89 holders.
  • The largest Core Scientific buyer in Q2 2024 was BlackRock, an estimated $62.2M added.
  • The largest Core Scientific seller in Q2 2024 was Barings, an estimated $36.5M sold.

Based on aggregated 13F filings for Q2 2024.